Amundi

A material impact from COVID-19

25/03/20 -"We are slashing our EPS going into 2020 and 2021 due to both market effects (net outflows on profitable products as, even if assets might remain in the company, when investors convert risky assets ..."

PDF page sample
Pages
53
Language
English
Published on
25/03/20
Download
You may also be interested by these reports :
28/11/25
Unsurprisingly, the French Supreme Court cancelled the judgement of the Paris Appeal Court but asked the Paris Appeal Court to judge again if Bolloré ...
28/11/25
Following the release of the more detailed 9M report, we have improved our EPS for 2025, mainly due to lower depreciation costs expected for 2025 ...
26/11/25
HAL continued its momentum in Q3 2025 by recording a slight increase in NAV, supported by its private assets. However, the performance was mixed ...
25/11/25
How Ackermans turns discipline into returns

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO